Pharmaceutical Contract Manufacturing (PCM) - Forecast to 2030 is estimated to be worth $100,102.8 million by 2030

According to IQ4I analysis, the pharmaceutical contract manufacturing (PCM) global market is expected to grow at a mid single digit CAGR from 2023 to 2030 to reach $100,102.8 million by 2030. The market is being propelled by several factors, including the increased trend of outsourcing and high uptake of small molecules drugs across diverse therapeutics are driving the pharmaceutical contract manufacturing global market. Whereas, patent expiration and increasing adoption of 505(b)(2) pathway of small molecules drugs, advanced technologies in API and FDF manufacturing, increasing R&D expenditures and Capacity and Capability Expansion in advanced Highly Potent APIs and Complex Molecules platforms are providing immense opportunities to the market. However, contamination of pharmaceutical products (API and FDF), pricing pressure for pharmaceutical contract manufacturing, requirement of highly skilled technicians, increasing biologics approvals and adoption in disease management, stringent regulatory policies, and environmental concerns are some of the factors that are hindering pharmaceutical contract manufacturing global market growth.

The report covers business intelligence information of the pharmaceutical contract manufacturing global market segments based on product, application, and geography. Revenue forecast and strategic analysis with respect to industry trends and contribution to the overall pharmaceutical contract manufacturing global market. Analysis technological trends, overall market share, market share analysis of major players, deals analysis, production volume analysis, ANDA approvals, patent analysis, DMF analysis, supply chain of and PCM product matrix. Identification of major market trends, factors driving, restraining, threatening and providing opportunities for the pharmaceutical contract manufacturing market growth. Major players' company profiles in the pharmaceutical contract manufacturing Global market and analysis of their business strategies and market shares.

The major companies in pharmaceutical contract manufacturing are AbbVie Inc (AbbVie Contract Manufacturing) (U.S.), Asymchem Laboratories (Tianjin) (China), Cambrex Corporation (U.S.), Curia (U.S.), Delpharm (France), Lonza Group (Switzerland), Porton Pharma Solutions Ltd (China), Recipharm (Sweden), Thermo Fisher Scientific (U.S.) and WuXi AppTec (China).

IQ4I (Intelligence Quotient for Innovation) Research and Consultancy Pvt. Ltd.
No 41/P4, Industrial Suburb
1st Floor, 3rd Main Road
1st Phase, KIADB Industrial Area
Peenya, Bangalore-560058

Mr. Satish Birudukota,
Website: https://www.iq4i.com
Report link: https://iq4i.com/report-store/
Email: bd@iq4i.com, satish.birudukota@iq4i.com,
Phone: +91-9886722024, 8147030229,

IQ4I (Intelligence Quotient for Innovation) Research and Consultancy Pvt. Ltd. is a global strategy, consulting and a leading market research company. Our clients include leading businesses, investment banks, researchers and government agencies.

We are a team of highly qualified consultants and market researchers, committed to help clients make strategic decisions by providing relevant and firmly reliable market intelligence support. We enable our clients to identify the market opportunities with best-in-class market intelligence reports.

With world-class research capabilities, we deliver high-level strategically analyzed consulting and custom research assignments to our clients at a reasonable cost and time frame. With fact-based insights and accurate market forecasts, we enable our clients to understand and respond to the market dynamics with an edge over their competitors.

This release was published on openPR.